Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

Feb 24, 2011

30339_dirs_2011-02-24_59184237-ec64-40b6-afc8-580a326379ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-22

Reporting Person: Hunt Jeffrey C (VP Pharma Pckg Systems)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-22 Common Stock A 631.0000 $40.8500 Acquired 631.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-22 Stock Option (Right to Buy) $40.8500 A 22831.0000 Acquired 2021-02-22 Common Stock (22831.0000) Direct

Footnotes

F1: Bonus and incentive shares granted on 02/22/2011.